他莫昔芬耐药乳腺癌对特异性抗雌激素（ICI182780）的反应。 - Suppr

Suppr

超能文献

Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancer.

作者信息

Dowsett M, Johnston S R, Iveson T J, Smith I E

出版信息

Lancet. 1995 Feb 25;345(8948):525. doi: 10.1016/s0140-6736(95)90624-x.

DOI:10.1016/s0140-6736(95)90624-x

PMID:7861903

Abstract

摘要

相似文献

Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancer.他莫昔芬耐药乳腺癌对特异性抗雌激素（ICI182780）的反应。

Lancet. 1995 Feb 25;345(8948):525. doi: 10.1016/s0140-6736(95)90624-x.

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer.他莫昔芬耐药乳腺癌对特定抗雌激素（ICI 182780）的反应。

Lancet. 1995 Apr 15;345(8955):989-90. doi: 10.1016/s0140-6736(95)90739-4.

Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes.原发性乳腺癌短期抗雌激素治疗对雌激素受体mRNA和蛋白质表达以及雌激素调节基因的影响。

Breast Cancer Res Treat. 1996;41(1):31-41. doi: 10.1007/BF01807034.

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer.他莫昔芬耐药性乳腺癌对特定抗雌激素（ICI 182780）的反应

Lancet. 1995 Jan 7;345(8941):29-30. doi: 10.1016/s0140-6736(95)91156-1.

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.氟维司群：一种具有新型作用机制的雌激素受体拮抗剂。

Br J Cancer. 2004 Mar;90 Suppl 1(Suppl 1):S2-6. doi: 10.1038/sj.bjc.6601629.

Development of novel oestrogen-receptor antagonists.新型雌激素受体拮抗剂的研发。

Biochem Soc Trans. 1991 Nov;19(4):899-901. doi: 10.1042/bst0190899.

Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health.乳腺癌的激素治疗，重点是纯抗雌激素氟维司群：作用机制、抗肿瘤疗效及对骨骼健康的影响

Expert Opin Drug Saf. 2008 May;7(3):241-58. doi: 10.1517/14740338.7.3.241.

Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.氟维司群：用于抗雌激素治疗后疾病进展的绝经后激素受体阳性转移性乳腺癌女性患者的应用综述

Drugs. 2004;64(6):633-48. doi: 10.2165/00003495-200464060-00009.

Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.4-羟基他莫昔芬及新型纯抗雌激素药物（ICI 182780）对人乳腺癌细胞体外克隆生长的影响

Br J Cancer. 1994 Aug;70(2):204-11. doi: 10.1038/bjc.1994.281.

Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.雌激素诱导他莫昔芬耐药的MCF-7细胞死亡：雌激素受体下调剂氟维司群的相反作用。

J Steroid Biochem Mol Biol. 2006 Mar;98(4-5):193-8. doi: 10.1016/j.jsbmb.2005.10.003. Epub 2006 Feb 7.

引用本文的文献

Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers.激素依赖性癌症的治疗进展：聚焦于前列腺癌、乳腺癌和卵巢癌。

Endocr Connect. 2019 Feb 1;8(2):R10-R26. doi: 10.1530/EC-18-0425.

2-Phenylacetamide Isolated from the Seeds of and Its Estrogen-Like Effects In Vitro and In Vivo.2-苯乙酰胺从种子中分离及其体外和体内的雌激素样作用。

Molecules. 2018 Sep 7;23(9):2293. doi: 10.3390/molecules23092293.

Estrogenic Effects of the Extracts from the Chinese Yam (Dioscorea opposite Thunb.) and Its Effective Compounds in Vitro and in Vivo.山药（薯蓣）提取物及其有效成分的体内外雌激素效应。

Molecules. 2018 Jan 23;23(2):11. doi: 10.3390/molecules23020011.

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.新型抗雌激素药物艾多昔芬可抑制人MCF-7乳腺癌异种移植瘤的生长，并降低获得性抗雌激素耐药的发生率。

Br J Cancer. 1997;75(6):804-9. doi: 10.1038/bjc.1997.144.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验